Slate Path Capital LP 13D/13G Filings for Cue Biopharma, Inc. (CUE)

Slate Path Capital LP 13D and 13G filings for Cue Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
5:00 pm
Sale		 2024-12-31 13G Cue Biopharma, Inc.
CUE		 Slate Path Capital LP 918,836
1.400%		 -1,483,619decrease
(-61.75%)		 Filing
2023-02-14
09:30 am
Unchanged		 2022-12-31 13G Cue Biopharma, Inc.
CUE		 Slate Path Capital LP 2,402,455
5.600%		 0
(Unchanged)		 Filing
2022-11-18
4:04 pm
Purchase		 2022-11-16 13G Cue Biopharma, Inc.
CUE		 Slate Path Capital LP 2,402,455
5.600%		 2,402,455increase
(New Position)		 Filing